St. Jude Medical, Inc.

  • This Medical Device Maker Seems to Be Quite Expensive

    By Anh HOANG - July 29, 2013 | Tickers: BSX, MDT, STJ

    Since the beginning of the year, Boston Scientific (NYSE: BSX) has enjoyed a great rally, climbing from $5.90 per share to nearly $11 per share. Its year-to-date return is nearly 91%, much higher than the S&P 500’s return of only 18.60%. In the first quarter, while Joel Greenblatt and Paul Tudor Jones reduced their positions in this company, Leon Cooperman and Jim Simons increased their exposure more »

  • This Healthcare Stock Can Continue Its Rally

    By Piyush Arora - July 29, 2013 | Tickers: BAX, BDX, STJ

    Thanks to an expanding product portfolio, increasing healthcare spending, and explosive growth in the emerging markets, the healthcare industry has been growing at a stellar rate lately. Medical supplies and equipment providers are benefiting the most, as they serve the global healthcare industry. One of the most prominent beneficiaries has been Becton Dickinson (NYSE: BDX), which has recorded an appreciation of 45% over the last year. But, despite the recent more »

  • Healthcare Stocks to Consider Buying

    By David Gould - July 26, 2013 | Tickers: ABT, ABBV, LLY, STJ

    Note: This article has been amended to remove TRADJENTA as Eli Lilly's leading products--it is developed and commercialized through an alliance between Eli Lilly and Boehringer Ingelheim International GmbH & Co

    To address the patent cliff, several large pharmaceutical companies have been actively reinventing their businesses in terms of pipeline updates and strategic changes. Below, I present my take on two leading producers with a focus on the headwinds and more »

  • Is This the Market's Last Remaining Bargain?

    By Ted Cooper - July 23, 2013 | Tickers: BSX, MDT, STJ

    It is hard to remember a time when the market was as overheated as it is today; even during the tech bubble, there were non-tech stocks that were cheap. Today, few stocks in any sector are even worth a closer look based on earnings multiples.

    However, one company -- Medtronic (NYSE: MDT) -- may be the last remaining bargain in this bull market. Medtronic sells at a steep discount to its peers more »

  • Is Now the Time to Buy Medical Device Makers?

    By Jason Hall - July 18, 2013 | Tickers: BSX, MAKO, MDT, STJ, SYK

    As of this writing, the S&P 500 is up over 17% this year, while many of the biggest names in medical devices have run even farther. If we go back to last June 28 -- when the US Supreme Court ruled in favor of Obamacare and its 2.3% excise tax on medical device makers' gross revenues, medical device stocks have run even higher. Motley Fool Contributor Dan Caplinger described more »

  • This Momentum Play Might Make You Money

    By Dan Moskowitz - July 15, 2013 | Tickers: BSX, MDT, STJ

    Boston Scientific (NYSE: BSX) isn't the most popular stock on Wall Street. In fact, many investors don't want to have anything to do with it. It would be difficult to blame those investors, considering the company has seen revenue declines for three consecutive years and reported losses in four of the last five. The company’s recent performance hasn't been much better, reporting losses in three of more »

  • Does the Decline in Health Care Spending Spell Trouble for These Companies?

    By Madhukar Dubey - July 9, 2013 | Tickers: BSX, STJ, ZMH

    Over the last few years the global healthcare industry has witnessed significant growth with most countries spending enormously on healthcare. The expenditure on health care varies widely; the U.S. spends the most, at approximately $8,500 per person in 2012.

    However, the outlook beyond 2013 looks hazy. Industry experts believe there could be a possible expenditure reduction of as much as $400 billion in the next three years by more »

  • Is This Stock in Your Portfolio? If Not, Then Consider Getting Some

    By Harsh Chauhan - July 2, 2013 | Tickers: BSX, MDT, STJ

    The market gives investors a good number of chances to buy stocks when they are beaten down, and one such opportunity presented itself when medical devices maker Medtronic (NYSE: MDT) slipped in February this year. There were concerns about the company’s business slowing down, but its fourth-quarter results, which were released in May, put such doubts to rest.

    Medtronic’s huge size and diversification have helped the company overcome more »

  • A Discounted Medical Equipment Play

    By Matthew Frankel - June 19, 2013 | Tickers: BDX, MDT, STJ

    When it comes to investing in the healthcare sector, there is lots of money to be made if investors choose wisely. Factors such as the current healthcare laws, which require a greater number of people to be insured, as well as an aging population should translate to higher spending on medical care over the next several years and beyond. My favorite way to play the sector over the long-term is more »

  • Is This Fallen Angel Still a Good Growth Play?

    By Palwasha Saaim - June 11, 2013 | Tickers: EW, MDT, STJ

    Healthcare stocks resemble tech stocks, in that both are eye candy to growth investors, show volatility over business cycles and thus have less appeal to value investors. Conclusively, it is important for growth investors to understand that if they pick high-growth companies with a strong market presence, they are likely to reap greater rewards during down markets than up markets. The reason is obvious. During down markets, the stronger companies more »

  • Bright Outlook for Device Makers

    By Ted Cooper - April 28, 2013 | Tickers: BSX, MDT, STJ | Editor's Choice

    In my last article, I argued that Medtronic (NYSE: MDT), Boston Scientific (NYSE: BSX), and St. Jude Medical (NYSE: STJ) were potentially-attractive investments. However, I made a key assumption in the article that is undoubtedly false: I assumed that each company's operations will stay the exact same from now into eternity.

    Although the assumption is false, it is a useful starting point for further analysis. The goal of this more »

  • Obamacare Uncertainty Presents Opportunity

    By Ted Cooper - April 26, 2013 | Tickers: BSX, MDT, STJ

    Health care companies have been caught in a state of limbo since the passage of Obamacare. The market is still sorting out who wins and who loses from the landmark health care overhaul. Meanwhile, Congress has plans to repeal or amend parts of the law. All of this leads to uncertainty about these companies' futures. However, the market's indecisiveness poses as an opportunity for enterprising investors to scoop up more »

  • St. Jude Medical news raises investors’ heartbeat

    By Shas Dey - April 15, 2013 | Tickers: BSX, MDT, STJ

    Exciting news came out for St. Jude Medical (NYSE: STJ) shareholders as the company announced that its product, the AMPLATZER Cardiac Plug (ACP), was going into a key phase of clinical trial testing. The ACP is used for the prevention of stroke and the clinical trial is being conducted to demonstrate whether the ACP device is both able and safe to prevent blood clots from travelling out of the left more »

  • Buying the Boston Boom

    By Marshall Hargrave - April 14, 2013 | Tickers: ABT, BSX, MDT, STJ

    Boston Scientific (NYSE: BSX) has rallied nicely year to date, up over 35%, but is there still room to grow for this heart-related devices company? Cardiovascular disease remains the number one killer worldwide. The number of adults diagnosed with heart disease in the U.S. is around 11.8 percent of the total population. 
     
    Earlier this year Boston revised growth plans to better account for the challenging economic environment. Boston more »
  • Edwards Lifesciences: A Strong Buy on Recent Dip

    By Palwasha Saaim - March 20, 2013 | Tickers: EW, MDT, STJ

    Back in October, when Edwards Lifesciences (NYSE: EW) missed earnings forecasts and the stock plummeted to its lowest in 10 years, I rated it a buy. If you had listened, you would have profited from the rally that followed. Now, after three months, history is repeating itself. 

    Edwards Lifesciences is a medical device manufacturer and holds a monopoly-like position in the U.S. for its Transcatheter Heart Valve (THV) called more »

  • How the ACA’s Tax Provisions Affect the Medical Device Sector

    By Kyle Colona - March 13, 2013 | Tickers: JNJ, MDT, STJ

    This article is brief look at the medical device excise tax under the Affordable Care Act and its affect on medical device companies.

    What is the Medical Device Excise Tax?

    The $20 billion tax went into play on January 1. That figure is based on a 2.3 percent tax being levied on the total revenues of a medical device company whether or not the outfit generates a profit. According more »

  • Reasons To Buy These Healthcare Stocks

    By David Gould - March 8, 2013 | Tickers: BAX, MDT, STJ

    If you are looking to diversify into the healthcare sector with lower downside, the medical device industry could be the one for you. This slice of the sector is more predictable than pharmaceutical producers, since the products tend to have a more clear cut science before any dollars are put into R&D. Below, I review two leaders in this field, Baxter and Medtronic.

    Baxter (NYSE: BAX)

    Baxter is a more »

  • Post-Earnings Sell-Off has Created a Buying Opportunity in This Stock

    By Harsh Chauhan - February 22, 2013 | Tickers: JNJ, MDT, STJ

    Medical devices maker Medtronic’s (NYSE: MDT) recently reported third-quarter results turned out to be a departure from normal. The company, for a change, missed the Street’s revenue expectations by a whisker but it did manage to deliver an earnings beat. The stock shed a total of 5% after earnings on fears of a slowdown in its European business while sluggish sales of heart and spinal devices added to more »

  • A Look at 2 Leading Medical Device Stocks

    By David Gould - February 18, 2013 | Tickers: BAX, MDT, STJ

    Medical device companies face significant opportunities from targeting the retiring baby boomer generation. Device innovations in blood disorders and heart conditions have gotten a large focus, but the foray into drug development has caught many analysts by surprise. Will this pay dividends? And what other strategies are they taking to hedge against domestic headwinds? Below, I present my take on Baxter and Medtronic.

    Baxter (NYSE: BAX)

    Baxter is a leading more »

  • Should Investors Give Their Heart To This Company?

    By sayar bachhawat - January 23, 2013 | Tickers: BSX, MDT, STJ

    The other day, my neighbor had a sudden heart attack and was rushed to the hospital. He underwent treatment and came back home with a stent in his artery. I noticed that he wasn’t alone, and that heart ailments and diseases are a common occurrence affecting almost every US household. As an investor, it made me think of the companies that are manufacturing such devices used for medical treatment more »

  • Page 1 of 3